EUVIMED · CrossrefZeitschrift
Journal of Nuclear Medicine
ISSN 0161-5505 · Society of Nuclear Medicine
Neueste Artikel
Comparable Daughter Radionuclide Redistribution with Superior Tumor Absorbed Dose of the SSTR2 Antagonist [ 225 Ac]Ac-SSO110 Versus [ 225 Ac]Ac-DOTATATE
Prostate-Specific Membrane Antigen PET/CT Segmentation Guided by Vision Language Models Embedding Clinical Report Semantics
Test–Retest Repeatability of Peripheral Ganglion Uptake on 18 F-DCFPyL PET/CT: Implications for Interpreting Benign Uptake on PSMA PET
Total-Body 18 F-FAPI PET/CT for Assessment of Metabolic Dysfunction–Associated Steatotic Liver Disease: A Pilot Study
Donor Site Evaluation Using Multispectral Optoacoustic Tomography in Patients with Head and Neck Cancer Who Require Free Flap Transplant Surgery
PSMA Total Tumor Volume: A Simple Quantifiable Biomarker for Overall Survival Prediction—Results from the International PROMISE PET Registry
A SPECT-Guided, PET-Sparing Algorithm for PSMA Radiopharmaceutical Therapy Evaluation (SPARE)
Appropriate Use Criteria for 18 F-Floretyrosine (FET) PET Imaging in Patients with Primary Brain Tumors
2026 SNMMI Highlights Lecture: Oncology and Therapy
Science, Mentorship, and Total-Body PET: A Conversation Between Simon Cherry and Johannes Czernin
From Nobel-Winning Science to Real-World Impact: Carolyn Bertozzi Talks with Ken Herrmann on Discovery, Entrepreneurship, and Leadership
Preclinical Physiologically Based Pharmacokinetic Modeling of PSMA Radioligands: Demonstrating Nonspecific Retention and Reversible Albumin-Binding Effects
PDGFRβ-Targeting VHH Tracer Enables Noninvasive PET Imaging of Kidney Fibrosis
Epidermal Growth Factor Receptor as a Radiotheranostic Target in Orthotopic Models of Hepatocellular Carcinoma
Clinical Study Protocol for PENTILULA: A Phase 1/2 Study Assessing [ 177 Lu]Lu-Pentixather for Relapsed or Refractory CXCR4-Positive Acute Leukemia
Patient Communication and Radiation Safety in [ 177 Lu]Lu-PSMA Radiopharmaceutical Therapy: International Survey of 102 Theranostic Centers
Comparative Evaluation of [ 68 Ga]Ga-FAPI-04 PET Versus Conventional Imaging for Peritoneal Carcinomatosis Detection in Ovarian Carcinoma: A Multimodal Imaging Study
Evaluating Suspected Tumor Recurrence with Epidermal Growth Factor Receptor–Targeted [ 89 Zr]Zr-Panitumumab PET/CT
[ 68 Ga]Ga-NODAGA-SNA006 PET/CT Reveals CD8 + T-Cell Dynamics in Lung Cancer Progression and Anti–PD-1 Response
PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study
Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates
Targeted PET Imaging of Pseudomonas aeruginosa Using a [ 68 Ga]Ga-Pyoverdines Cocktail
Safety, Biodistribution, and Dosimetry of FAP and Integrin α v β 3 Dual-Targeting Radioligand 177 Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas
Hematologic Consequences of Radiopharmaceutical Therapy: From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms
68 Ga-FAPI PET/CT for Differentiation of Malignant Peripheral Nerve Sheath Tumors, Neurofibromas, and Schwannomas
PSMA PET/CT and Multiparametric MRI Before Prostate Biopsy
PET Imaging of Tumor-Associated Macrophage Dynamics and Response to Clinical Treatment for Potential Translation
CXCR4-Targeted Molecular Imaging in Hematology and Oncology
Contribution of Myelin Content to the PET-Measured Amyloid Burden
Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [ 177 Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer
EUVIMED